Ceribell (CBLL) Share-based Compensation (QoQ) (2023 - 2026)
Ceribell (CBLL) Share-based Compensation (QoQ) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Ceribell | 647.81 Mn | 506.62 Mn | 23.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.84% |
| Dec 31, 2025 | 0.30% |
| Sep 30, 2025 | 5.75% |
| Jun 30, 2025 | 34.88% |
| Mar 31, 2025 | -49.32% |
| Dec 31, 2024 | 236.70% |
| Sep 30, 2024 | 27.88% |
| Jun 30, 2024 | 42.14% |
| Mar 31, 2024 | 1.61% |
| Dec 31, 2023 | 16.95% |